A detailed history of Expect Equity LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Expect Equity LLC holds 30,924 shares of HAE stock, worth $2.27 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares
30,924
Previous 21,224 45.7%
Holding current value
$2.27 Million
Previous $1.58 Billion 4.82%
% of portfolio
1.47%
Previous 1.69%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$47.67 - $78.17 $462,399 - $758,249
9,700 Added 45.7%
30,924 $1.51 Billion
Q2 2025

Aug 14, 2025

BUY
$56.04 - $74.77 $169,464 - $226,104
3,024 Added 16.62%
21,224 $1.58 Billion
Q1 2025

May 15, 2025

BUY
$59.34 - $80.05 $243,294 - $328,205
4,100 Added 29.08%
18,200 $1.16 Billion
Q4 2024

Feb 14, 2025

BUY
$71.16 - $93.38 $1 Million - $1.32 Million
14,100 New
14,100 $1.1 Billion

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Expect Equity LLC Portfolio

Follow Expect Equity LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Expect Equity LLC, based on Form 13F filings with the SEC.

News

Stay updated on Expect Equity LLC with notifications on news.